CorMedix Inc. - 8-K Filing

CorMedix reaffirms 2026 revenue guidance of $325M-$345M and reports $355M in cash as of September 30, 2026. (Items: 2.02 Results of Operations and Financial Condition On November 2, 2026, CorMedix Inc, 7.01 Regulation FD Disclosure On November 2, 2026, the Company issued a press release providing a business update and announcing the Company’s cas, 9.01 Financial Statements and Exhibits (d) Exhibits Exhibit No)

SEC EDGAR · November 2, 2026, 12:39 UTC

Tickers: $CRMD

Read the full article at SEC EDGAR

Part of the story ILLINOIS TOOL WORKS INC - 8-K Filing (139 articles)

More Regulatory news

Solana Co - 10-Q Filing SEC EDGAR · November 12, 2026, 13:42 UTC
Solana Co - 8-K Filing SEC EDGAR · November 12, 2026, 13:41 UTC
DeFi Development Corp. - 8-K Filing SEC EDGAR · November 12, 2026, 13:41 UTC
Stablecoin Development Corp - 8-K Filing SEC EDGAR · November 12, 2026, 13:40 UTC
BCP Investment Corp - 8-K Filing SEC EDGAR · November 12, 2026, 13:36 UTC
OneWater Marine Inc. - 8-K Filing SEC EDGAR · November 12, 2026, 13:37 UTC
Moleculin Biotech, Inc. - 8-K Filing SEC EDGAR · November 12, 2026, 13:37 UTC
Investcorp Credit Management BDC, Inc. - 8-K Filing SEC EDGAR · November 12, 2026, 13:37 UTC
Presurance Holdings, Inc. - 10-Q Filing SEC EDGAR · November 12, 2026, 13:35 UTC
Corteva, Inc. - 8-K Filing SEC EDGAR · November 12, 2026, 13:34 UTC